Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro

Stem Cells

Volumn 24, Issue 5, 2006, Pages 1226-1235

  Ebert, Regina ^a   Ulmer, Matthias ^a   Zeck, Sabine ^a   Meissner Weigl, Jutta ^a   Schneider, Doris ^a   Stopper, Helga ^a   Schupp, Nicole ^a   Kassem, Moustapha ^b   Jakob, Franz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bone marrow stromal cells; Micronuclei; Reactive oxygen species; Selenoproteins; Tissue engineering

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SELENIUM; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL PROTECTION; HEMATOPOIETIC STEM CELL; MESENCHYME CELL; MICRONUCLEUS; NONHUMAN; OXIDATIVE STRESS; STROMA CELL;

BASE SEQUENCE; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA; DNA DAMAGE; HUMANS; MESENCHYMAL STEM CELLS; MICRONUCLEUS TESTS; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SELENIUM; STROMAL CELLS;

EID: 33747595991     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0117     Document Type: Article

References (71)

1. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003;5:32-45
2. Cancedda R, Dozin B, Giannoni P et al. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003;22:81-91.
3. Caplan AI, Bruder SP. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-264.
4. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118-121.
5. Nöth U, Osyczka AM, Tuli R et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002;20:1060-1069.
6. Pelled GGT, Aslan H, Gazit Z et al. Mesenchymal stem cells for bone gene therapy and tissue engineering. Curr Pharm Des 2002;8:1917-1928.
7. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: Nature, biology, and potential applications. STEM CELLS 2001;19:180-192.
8. Turgeman G, Aslan H, Gazit Z et al. Cell-mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 2002;4:390-394.
9. Köhrle J, Jakob F, Dumont J. Selenium and the endocrine system. Endocr Rev 2005;26:944-984.
10. Ghezzi P, Bonetto V. Redox proteomics: Identification of oxidatively modified proteins. Proteomics 2003;3:1145-1153.
11. Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst) 3:1109-1115, 2004.
12. Stopper H, Meysen T, Bockenforde A et al. Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy. Am J Kidney Dis 1999;34:433-437.
13. Stopper H, Hempel K, Reiners C et al. Pilot study for comparison of reticulocyte-micronuclei with lymphocyte-micronuclei in human biomonitoring, Toxicol Lett 2005;156:351-360.
14. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 2002;7:1128-1137.
15. Fenech M. In vitro micronucleus technique to predict chemosensitivity. Methods Mol Med 2005;111:3-32.
16. Fenech M. The Genome Health Clinic and Genome Health Nutrigenomics concepts: Diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 2005;20:255-269.
17. Ruppitsch W, Meisslitzer C, Hirsch-Kauffmann M et al. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett 1998;422:99-102.
18. Kontou M, Adelfalk C, Ramirez MH et al. Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability. Oncogene 2002;21:2406-2412.
19. Kirkwood TB, Austad SN. Why do we age? Nature 2000;408:233-238.
20. Aigaki T, Seong KH, Matsuo T. Longevity determination genes in Drosophila melanogaster. Mech Ageing Dev 2002;123:1531-1541.
21. Toussaint O, Royer V, Salmon M et al. Stress-induced premature senescence and tissue ageing. Biochem Pharmacol 2002;64:1007-1009.
22. Smith SK, Kipling D. The role of replicative senescence in cancer and human ageing: Utility (or otherwise) of murine models. Cytogenet Genome Res 2004;105:455-463.
23. Kipling D, Davis T, Ostler EL et al. What can progeroid syndromes tell us about human aging? Science 2004;305:1426-1431.
24. Ito K, Hirao A, Arai F et al. Regulation of oxidative stress by ATM is required for self renewal of hematopoetic stem cells. Nature 2004;431:997-1002.
25. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002;33:337-349.
26. Noor R, Mittal S, Iqbal J. Superoxide dismutase: Applications and relevance to human diseases. Med Sci Monit 2002;8:RA210-RA215.
27. Kirby K, Hu J, Hilliker AJ et al. RNA interference-mediated silencing of Sod2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress. Proc Natl Acad Sci U S A 2002;99:16162-16167.
28. Huang TT, Carlson EJ, Raineri I et al. The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann N Y Acad Sci 1999;893:95-112.
29. Huang TT, Raineri I, Eggerding F et al. Transgenic and mutant mice for oxygen free radical studies. Methods Enzymol 2002;349:191-213.
30. Andreassen OA, Ferrante RJ, Dedeoglu A et al. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp Neurol 2001;167:189-195.
31. Asikainen TM, Huang TT, Taskinen E et al. Increased sensitivity of homozygous Sod2 mutant mice to oxygen toxicity. Free Radic Biol Med 2002;32:175-186.
32. Zhang J, Graham DG, Montine TJ et al. Enhanced N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol 2000;59:53-61.
33. Copin JC, Gasche Y, Chan PH. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic Biol Med 2000;28:1571-1576.
34. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991;266:11632-11639.
35. Chang MS, Lee SG, Rho HM. Transcriptional activation of Cu/Zn superoxide dismutase and catalase genes by panaxadiol ginsenosides extracted from Panax ginseng. Phytother Res 1999;13:641-644.
36. Chang MS, Yoo HY, Rho HM. Positive and negative regulatory elements in the upstream region of the rat Cu/Zn-superoxide dismutase gene. Biochem J 1999;339:335-341.
37. Kim HT, Kim YH, Nam JW et al. Study of 5′-flanking region of human Cu/Zn superoxide dismutase. Biochem Biophys Res Commun 1994;201:1526-1533.
38. Kim YH, Yoo HY, Chang MS et al. C/EBP alpha is a major activator for the transcription of rat Cu/Zn superoxide dismutase gene in liver cell. FEBS Lett 1997;401:267-270.
39. Minc E, de Coppet P, Masson P et al. The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites. J Biol Chem 1999;274:503-509.
40. Park EY, Rho HM. The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element. Mol Cell Biochem 2002;240:47-55.
41. Driscoll DM, Copeland PR. Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr 2003;23:17-40.
42. Kyriakopoulos A, Behne D. Selenium-containing proteins in mammals and other forms of life. Rev Physiol Biochem Pharmacol 2002;145:1-46.
43. Burk RF, Hill KE, Motley AK. Selenoprotein metabolism and function: Evidence for more than one function for selenoprotein P. J Nutr 2003;133:1517S-1520S
44. McKenzie RC, Arthur JR, Beckett GJ. Selenium and the regulation of cell signaling, growth, and survival: Molecular and mechanistic aspects. Antioxid Redox Signal 2002;4:339-351.
45. Jakob F, Becker K, Paar E et al. Expression and regulation of thioredoxin reductases and other selenoproteins in bone. Methods Enzymol 2002;347:168-179.
46. Ebert-Dümig R, Schütze N, Jakob F. The thioredoxin reductase/thioredoxin system in cells of the monocyte/macrophage pathway of differentiation. Biofactors 1999;10:227-235.
47. Schütze N, Fritsche J, Ebert-Dümig R et al. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells: Regulation by 1,25-dihydroxyvitamin D3 and selenite. Biofactors 1999;10:329-338.
48. Simonsen JL, Rosada C, Serakinci N et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002;20:592-596.
49. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
50. Schütze N, Nöth U, Schneidereit J et al. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation. Cell Commun Signal 2005;3:5.
51. Harris SA, Enger RJ, Riggs BL et al. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 1995;10:178-186.
52. Dreher I, Schmutzler C, Jakob F et al. Expression of selenoproteins in various rat and human tissues and cell lines. J Trace Elem Med Biol 1997;11:83-91.
53. Holmgren A, Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 1995;252:199-208.
54. Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-287.
55. Beauchamp CO, Fridovich I. Isozymes of superoxide dismutase from wheat germ. Biochim Biophys Acta 1973;317:50-64.
56. Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal Biochem 1989;179:8-18.
57. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002;30:e36.
58. Royall JA, Ischiropoulos H. Evaluation of 2′,7′- dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch Biochem Biophys 1993;302:348-355.
59. Kane DJ, Sarafian TA, Anton R et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993;262:1274-1277.
60. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukocyte Biol 1994;55:253-258.
61. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: Stem cells and their niche. Cell 2004;116:769-778.
62. Soti C, Sreedhar AS, Csermely P. Apoptosis, necrosis and cellular senescence: Chaperone occupancy as a potential switch. Aging Cell 2003;2:39-45.
63. de Boer J, Andressoo JO, de Wit J et al. Premature aging in mice deficient in DNA repair and transcription. Science 2002;296:1276-1279.
64. Bohr VA. DNA-related pathways defective in human premature aging. Scientific World Journal 2002;2:1216-1226.
65. Linton S, Davies MJ, Dean RT. Protein oxidation and ageing. Exp Gerontol 2001;36:1503-1518.
66. Mohaghegh P, Hickson ID. Premature aging in RecQ helicase-deficient human syndromes. Int J Biochem Cell Biol 2002;34:1496-1501.
67. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004;337:1-13.
68. Yoo HY, Chang MS, Rho HM. The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element. J Biol Chem 1999;274:23887-23892.
69. Serakinci N, Guldberg P, Burns JS et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004;23:5095-5098.
70. Saito Y, Yoshida Y, Akazawa T et al. Cell death caused by selenium deficiency and protective effect of antioxidants. J Biol Chem 2003;278:39428-39434.
71. Guan K, Furst DO, Wobus AM. Modulation of sarcomere organization during embryonic stem cell-derived cardiomyocyte differentiation. Eur J Cell Biol 1999;78:813-823.